Skip to content
Subscriber Only

Drought of IPOs in Hong Kong Coming to an End

  • Shanghai Henlius starts gauging investor demand Monday for IPO
  • No major listing has completed in Hong Kong since mid-July

The summer IPO drought in Hong Kong is coming to an end.

Shanghai Henlius Biotech Inc., a unit of billionaire Guo Guangchang’s Fosun group, started gauging investor demand Monday for a planned initial public offering, according to terms of the deal obtained by Bloomberg. The offering could raise at least $600 million, people with knowledge of the matter have said.